| Literature DB >> 30834055 |
Santosh Kumar Sinha1, Amit Goel1, Mahmodula Razi1, Mukesh Jitendra Jha1, Vikas Mishra1, Puneet Aggarwaal1, Ramesh Thakur1, Vinay Krishna1, Umeshwar Pandey1, Chandra Mohan Varma1.
Abstract
BACKGROUND: Positioning a permanent pacing wire in patients with persistent left superior vena cava (PLSVC) to right ventricle often comes as on-table surprise. It is technically demanding and therefore most of operators prefer left-sided approach. We assessed technical challenges during pacemaker implantation, and their short- and long-term outcomes among patients with isolated PLSVC from a right-sided approach.Entities:
Keywords: Alpha loop configuration; Coronary sinus; Lead dislodgement; Permanent pacemaker implantation; Persistent left superior vena cava
Year: 2019 PMID: 30834055 PMCID: PMC6396803 DOI: 10.14740/cr784
Source DB: PubMed Journal: Cardiol Res ISSN: 1923-2829
Figure 1(a) TTE showing dilated coronary sinus. (b) Contrast phlebography from right upper limb showing isolated PLSVC. (c) Mond’s curve. (d) Alpha loop configuration of ventricular lead (passive fixation lead).
Echocardiographic Diagnosis of Isolated Persistent Left Superior Vena Cava and Its Possible Variation With Contrast Injection (Agitated Saline)
| Agitated saline contrast | RSVC | Isolated PLSVC draining to RA | PLSVC with RSVC | LSVC draining into LA |
|---|---|---|---|---|
| Contrast from the left arm | RA | CS to RA | CS to RA | LA |
| Contrast from the right arm | RA | CS to RA | RA | RA |
LA: left atrium; PLSVC: persistent left superior vena cava; RSVC: right superior vena cava; RA: right atrium; CS: coronary sinus.
Figure 2(a) Characteristic lead positions in a lateral view. (b) An antero-posterior view. (c) CT venography showing isolated PLSVC. (d) Multiple detector computed tomography (MDCT) showing isolated PLSVC.
Baseline Characteristics of Patients (n = 124)
| Baseline characteristics | PM-PLSVC (n = 31, %) | PM-without PLSVC (n = 93, %) | P-value |
|---|---|---|---|
| Age (years) | 65.3 ± 11.6 | 64.4 ± 9.3 | 0.6 |
| Sex (men/women) | 19/12 | 57/36 | 0.5 |
| HTN | 6 (19%) | 22 (24%) | 0.4 |
| DM | 5 (16%) | 19 (21%) | 0.23 |
| Ejection fraction (%) | 62.5 ± 4 | 63.6 ± 5 | 0.34 |
| Pacing indication | |||
| SND | 13 (44%) | 42 (45%) | 0.18 |
| AV block | 13 (44%) | 34 (37%) | 0.16 |
| Chronic BFB and TFB | 05 (12%) | 17 (18%) | 0.2 |
| Types of pacemaker | |||
| VVI/VVIR | 09 (29) | 36 (39) | 0.4 |
| DDD/DDDR | 22 (71) | 57 (61) | 0.2 |
| Types of pacing electrode | |||
| Tiened | 05 (16) | 14 (15) | 0.3 |
| Screwing | 26 (84) | 79 (85) | 0.19 |
AV block: atrioventricular block; BFB: bifascicular block; DM: diabetes mellitus; EF: ejection fraction; HTN: hypertension; NYHA: New York Heart Association; PLSVC: persistent left superior vena cava; PM: pacemaker implantation; SND: sinus node dysfunction; TFB: trifascicular block.
Clinical and Procedural Outcomes of Patients (n = 124)
| Baseline characteristics | PM-PLSVC (n = 31, %) | PM-without PLSVC (n = 93, %) | P-value |
|---|---|---|---|
| Procedural time (min) | 25 ± 11 | 23 ± 12 | 0.24 |
| Fluroscopic time (min) | 3.1 ± 2.2 | 2.7 ± 2.1 | 0.54 |
| Length of leads (cm) | |||
| Atrial | 53 | 53 | NS |
| Ventricular | 58 | 58 | NS |
| Pacing parameters | |||
| Atrial lead | |||
| Threshold (mV) | 1.2 ± 0.1 | 1 ± 0.2 | 0.4 |
| P-wave (mV) | 4.1 ± 0.2 | 4.3 ± 0.1 | 0.5 |
| Lead impedance (Ω) | 580 ± 170 | 540 ± 140 | 0.2 |
| Ventricular lead | |||
| Threshold (mV) | 0.8 ± 0.3 | 0.9 ± 0.2 | 0.17 |
| R-wave (mV) | 14 ± 4 | 16 ± 1 | 0.32 |
| Lead impedance (Ω) | 800 ± 240 | 760 ± 20 | 0.22 |
| Alpha loop (ventricular lead) | 31 (100) | 00 | 0.002 |
| Lead dislodgement | 01 (3.2) | 03 (4.8) | 0.32 |
| Subclavian crush | 00 | 00 | 0.00 |
| Local site complication | 02 (6.4) | 07 (7.5) | 0.5 |
| Follow-up duration (years) | 6.9 ± 1.3 | 7.2 ± 1.1 | 0.18 |
PM: pacemaker implantation.